July 30, 2021
“Shares of Baker Hughes Co. rallied 0.8% in morning trading Friday, after the oilfield products and services company said it set a $2 billion stock repurchase program. Based Thursday’s stock closing price of $21.18, the buyback program represents about 9.1%… Continue Reading…
July 30, 2021
“The stock market was off its opening lows Friday morning as the Nasdaq composite took the hardest hit from weakness in Amazon.com (AMZN) in particular.Volume 0% Amazon.com slid nearly 7% after the company reported second-quarter sales that missed views and gave a disappointing forecast… Continue Reading…
July 30, 2021
“…The company posted better-than-expected earnings results on Tuesday, but Wall Street appears more excited about the industrial conglomerate’s improving cash flow. In addition to beating estimates, GE (ticker: GE) raised its full-year free-cash-flow guidance for its industrial operations to a midpoint of… Continue Reading…
July 28, 2021
“Mimecast, Ltd. (MIME)… Overall, MIME derives its Strong Buy consensus rating from 10 reviews, including 8 Buys and 2 Holds. The shares are trading for $55.24 and their $62.90 average price target suggests room for another 14% in price appreciation. Super… Continue Reading…
July 26, 2021
“Shares of Hasbro Inc. surged 2.3% in premarket trading Monday, after the toy maker reported a second-quarter adjusted profit that was more than double what was expected, as revenue got boosts from strength in franchise brands and Wizards of the… Continue Reading…
July 23, 2021
“J.P. Morgan analyst Jose Asumendi is the latest Street analyst to recommend caution. Wednesday, he launched coverage of QuantumScape (ticker: QS) with a Hold rating on its stock and a $35 price target. It’s a lukewarm rating. Still, QuantumScape stock is having a fine… Continue Reading…
July 23, 2021
“hares of Boston Beer tumbled 21% in premarket trading Friday after disappointing demand for hard seltzer dragged down the company’s quarterly earnings and revenue. The Sam Adams brewer reported earnings of $4.75 per share on net sales of $603 million. Analysts surveyed… Continue Reading…
July 19, 2021
“Ambrx Biopharma (AMAM)… This new biopharma stock has a Strong Buy rating from the analyst consensus, based on 3 positive reviews so far. The shares are priced at $19.56 and their $39.50 average target suggests room for an upside of 101%… Continue Reading…
July 9, 2021
“Aerpio Pharmaceuticals (ARPO) is a biopharmaceutical company focused on developing compounds that activate Tie2. Tie2 is considered a key regulator of vascular stability, and ARPO “believes that activation of Tie2 may have therapeutic potential” for different indications. In Q1, ARPO… Continue Reading…
June 30, 2021
“…”We view GE as the ultimate self-help, re-opening levered story in Industrials,” said Goldman Sachs analyst Joe Ritchie in a new research note on Tuesday. The analyst slapped a $16 price target on GE’s stock, representing about a 22% upside… Continue Reading…
Recent Comments